Top Clinical Trials companies in Ireland by Return on Capital Employed (ROCE)

This ranking features the top 8 Clinical Trials companies in Ireland ranked by Return on Capital Employed (ROCE), averaging a Return on Capital Employed (ROCE) of -51.34%, for February 08, 2025.
#
Name
Return on Capital Employed (ROCE)
Reported Date
Stock Price
Change
Price (30 days) Country
1
27.51%
Dec. 31, 2023 USD 31.53 -1.19%

Ireland

2
6.60%
Dec. 31, 2023 USD 199.08 -1.31%

Ireland

3
5.96%
Dec. 31, 2023 USD 124.37 -0.54%

Ireland

4
1.16%
Dec. 31, 2023 USD 69.87 -1.17%

Ireland

5
-18.88%
Dec. 31, 2023 USD 10.60 9.39%

Ireland

6
-29.87%
Dec. 31, 2023 USD 14.23 -3.20%

Ireland

7
-118.03%
Dec. 31, 2023 USD 7.90 2.73%

Ireland

8
-285.14%
Dec. 31, 2023 USD 1.60 1.91%

Ireland

Frequently Asked Questions
  • Which Clinical Trials company in Ireland has the highest Return on Capital Employed (ROCE) ?

    The Clinical Trials company in Ireland with the highest Return on Capital Employed (ROCE) is Alkermes plc (NasdaqGS: ALKS) at 27.51%.

  • Which Clinical Trials company in Ireland has the lowest Return on Capital Employed (ROCE) ?

    The Clinical Trials company in Ireland with the lowest Return on Capital Employed (ROCE) is Iterum Therapeutics plc (NasdaqCM: ITRM) at -285.14%.

SV Wall Street